Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Jan Westerink"'
Autor:
Gert J. de Borst, Rogier V. Immink, Jan Westerink, Daniel J. van Vriesland, Jean-Paul P.M. de Vries, Selma C. Tromp, Leonie M.M. Fassaert, Raechel J. Toorop, L. Jaap Kappelle
Publikováno v:
European journal of vascular and endovascular surgery, 58(3), 320-327. W.B. Saunders Ltd
European Journal of Vascular and Endovascular Surgery, 58(3), 320. W.B. Saunders Ltd
European Journal of Vascular and Endovascular Surgery, 58(3), 320-327. W B SAUNDERS CO LTD
European Journal of Vascular and Endovascular Surgery, 58(3), 320. W.B. Saunders Ltd
European Journal of Vascular and Endovascular Surgery, 58(3), 320-327. W B SAUNDERS CO LTD
Objectives Intra-operative transcranial Doppler (TCD) is the gold standard for prediction of cerebral hyperperfusion syndrome (CHS) in patients after carotid endarterectomy (CEA) under general anaesthesia. However, post-operative cerebral perfusion p
Publikováno v:
Diabetic Medicine, 36(9), 1125. Wiley-Blackwell
Diabetic Medicine
Diabetic Medicine
Aim To quantify the risk of different non‐invasive arterial stiffness measurements with macrovascular disease and all‐cause mortality in high‐risk people with Type 2 diabetes. Methods We conducted a prospective cohort study of 1910 people with
Autor:
Joris Holtrop, Harold W. de Valk, Wilko Spiering, Frank L.J. Visseren, Gert J. de Borst, L. J. Kappelle, Hendrik M. Nathoe, Jan Westerink
Publikováno v:
Journal of Hypertension, 38(1), 45. Lippincott Williams and Wilkins
OBJECTIVE: To evaluate whether the relationship between hypertension and type 2 diabetes mellitus (T2DM) is different for patients with uncontrolled hypertension, controlled hypertension or patients with apparent therapy-resistant hypertension (aTRH)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7139b57b09af9018ceafc120788192ce
https://dspace.library.uu.nl/handle/1874/392530
https://dspace.library.uu.nl/handle/1874/392530
Autor:
Jesper Hjortnaes, F.L.J. Visseren, Jan Westerink, Yolanda van der Graaf, Paul M. Ridker, Folkert W. Asselbergs, Joachim G.J.V. Aerts, Cilie C van 't Klooster
Publikováno v:
European Heart Journal, 40(48), 3901. Oxford University Press
Aims Low-grade inflammation, measured by elevated plasma concentrations of high-sensitive C-reactive protein (CRP), is a risk factor for cardiovascular disease (CVD). There is evidence that low-grade inflammation is also related to a higher risk of c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a418315da893e6449bcf5e46dfb1f7c
https://dspace.library.uu.nl/handle/1874/391905
https://dspace.library.uu.nl/handle/1874/391905
Autor:
Gert J. de Borst, Yolanda van der Graaf, Maarten J. Cramer, Jan Westerink, Tamar I de Vries, Harold W. de Valk, Frank L.J. Visseren, L. Jaap Kappelle
Publikováno v:
Diabetes Research and Clinical Practice, 157. Elsevier Ireland Ltd
Aims Thyroid dysfunction is a risk factor for cardiovascular disease. Whether thyroid function within the normal range is a risk factor for cardiovascular disease remains uncertain. The aim of this study is to evaluate whether plasma thyroid-stimulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19e5975cfc0ba16e42598d890a443d3f
https://dspace.library.uu.nl/handle/1874/388851
https://dspace.library.uu.nl/handle/1874/388851
Autor:
Jannick A N Dorresteijn, Tamar I de Vries, Frank L.J. Visseren, Yolanda van der Graaf, Jan Westerink
Publikováno v:
Diabetes Care
Diabetes Care, 42(10), 1988. American Diabetes Association Inc.
Diabetes Care, 42(10), 1988. American Diabetes Association Inc.
OBJECTIVE To explore the presence of heterogeneity of treatment effect (HTE) of an intensive lifestyle intervention on the occurrence of major cardiovascular events (MACE) in overweight or obese patients with type 2 diabetes, and to identify patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56bd3f36b6b98a9837b2a96948a642e
https://europepmc.org/articles/PMC7364666/
https://europepmc.org/articles/PMC7364666/
Autor:
W.J.P. van Boven, N. Wiersma, Jan Westerink, Vikash Hindori, Robert Riezebos, Rosemarijn Jansen, Timion A Meijs, B.J. Bouma, Einar A. Hart, Steven A. J. Chamuleau, Wilco Tanis, Thomas C. Dessing
Publikováno v:
International Journal of Cardiology, 232, 121–126. Elsevier Ireland Ltd
International journal of cardiology, 232, 121-126. Elsevier Ireland Ltd
International journal of cardiology, 232, 121-126. Elsevier Ireland Ltd
Background In preparation for an invasive procedure with a high bleeding risk, patients with a mechanical heart valve temporarily have to discontinue their anticoagulant therapy and are usually bridged with either intravenous unfractionated heparin (
Autor:
Frank L.J. Visseren, Hendrik M. Nathoe, Shahnam Sharif, Harold W. de Valk, Yolanda van der Graaf, Jan Westerink
Publikováno v:
Diabetes Care, 39(8), 1424. American Diabetes Association Inc.
OBJECTIVE To evaluate whether low HDL cholesterol (HDL-c) levels are a risk factor for cardiovascular disease and mortality in patients with type 2 diabetes and whether it remains a residual risk factor when attaining low LDL cholesterol (LDL-c) trea
Autor:
Gert J. de Borst, Jan Westerink, Pierre Amarenco, John J.P. Kastelein, Lotte Kaasenbrood, Frank L.J. Visseren, S. Matthijs Boekholdt, Maarten J. Cramer, John C. LaRosa, Kausik K. Ray, L. Jaap Kappelle, Yolanda van der Graaf, Ron J.G. Peters
Publikováno v:
Circulation, 134(19), 1419-1429. Lippincott Williams and Wilkins
Circulation, 134(19), 1419. Lippincott Williams and Wilkins
Circulation, 134(19), 1419. Lippincott Williams and Wilkins
Background: Among patients with clinically manifest vascular disease, the risk of recurrent vascular events is likely to vary. We assessed the distribution of estimated 10-year risk of recurrent vascular events in a secondary prevention population. W
Autor:
John W. Eikelboom, Scott D. Berkowitz, Marco Alings, Frank L.J. Visseren, Yolanda van der Graaf, Keith A.A. Fox, Tamar I de Vries, Jannick A N Dorresteijn, Jackie Bosch, Jan Westerink, Leanne Dyal
Publikováno v:
European Heart Journal, 40(46), 3771. Oxford University Press
Aims Adding rivaroxaban to aspirin in patients with stable atherosclerotic disease reduces the recurrence of cardiovascular disease (CVD) but increases the risk of major bleeding. The aim of this study was to estimate the individual lifetime treatmen